<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Li Q</submitter><funding>Natural Science Foundation of Zhejiang Province</funding><funding>National Natural Science Foundation of China</funding><pagination>8876484</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8087994</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>2021</volume><pubmed_abstract>Thrombospondin (TSP) proteins have been shown to impact T-cell adhesion, migration, differentiation, and apoptosis. Thrombospondin-1 (TSP-1) is specifically upregulated in several inflammatory diseases and can effectively promote lipopolysaccharide- (LPS-) induced inflammation. In contrast, thrombospondin-2 (TSP-2) has been associated with activation of "anti-inflammatory" T-regulatory cells (Tregs). In this study, we investigated the effects of both TSP-1 and TSP-2 overexpression on macrophage polarization and activation &lt;i>in vitro&lt;/i> and &lt;i>in vivo&lt;/i>. We analyzed the effects of TSP-1 and TSP-2 on inflammation, vascular endothelial permeability, edema, ultrastructural morphology, and apoptosis in lung tissues of an ARDS mouse model and cultured macrophages. Our results demonstrated that TSP-2 overexpression effectively attenuated LPS-induced ARDS &lt;i>in vivo&lt;/i> and promoted M2 macrophage phenotype polarization &lt;i>in vitro&lt;/i>. Furthermore, TSP-2 played a role in regulating pulmonary vascular barrier leakage by activating the PI3K/Akt pathway. Overall, our findings indicate that TSP-2 can modulate inflammation and could therefore be a potential therapeutic target against LPS-induced ARDS.</pubmed_abstract><journal>Mediators of inflammation</journal><pubmed_title>Contribution of Thrombospondin-1 and -2 to Lipopolysaccharide-Induced Acute Respiratory Distress Syndrome.</pubmed_title><pmcid>PMC8087994</pmcid><funding_grant_id>LY19H1500003</funding_grant_id><funding_grant_id>81801552</funding_grant_id><funding_grant_id>81971069</funding_grant_id><pubmed_authors>Fu X</pubmed_authors><pubmed_authors>Li Q</pubmed_authors><pubmed_authors>Han S</pubmed_authors><pubmed_authors>Yuan J</pubmed_authors></additional><is_claimable>false</is_claimable><name>Contribution of Thrombospondin-1 and -2 to Lipopolysaccharide-Induced Acute Respiratory Distress Syndrome.</name><description>Thrombospondin (TSP) proteins have been shown to impact T-cell adhesion, migration, differentiation, and apoptosis. Thrombospondin-1 (TSP-1) is specifically upregulated in several inflammatory diseases and can effectively promote lipopolysaccharide- (LPS-) induced inflammation. In contrast, thrombospondin-2 (TSP-2) has been associated with activation of "anti-inflammatory" T-regulatory cells (Tregs). In this study, we investigated the effects of both TSP-1 and TSP-2 overexpression on macrophage polarization and activation &lt;i>in vitro&lt;/i> and &lt;i>in vivo&lt;/i>. We analyzed the effects of TSP-1 and TSP-2 on inflammation, vascular endothelial permeability, edema, ultrastructural morphology, and apoptosis in lung tissues of an ARDS mouse model and cultured macrophages. Our results demonstrated that TSP-2 overexpression effectively attenuated LPS-induced ARDS &lt;i>in vivo&lt;/i> and promoted M2 macrophage phenotype polarization &lt;i>in vitro&lt;/i>. Furthermore, TSP-2 played a role in regulating pulmonary vascular barrier leakage by activating the PI3K/Akt pathway. Overall, our findings indicate that TSP-2 can modulate inflammation and could therefore be a potential therapeutic target against LPS-induced ARDS.</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021</publication><modification>2026-06-12T03:13:30.731Z</modification><creation>2026-06-12T03:08:34.191Z</creation></dates><accession>S-EPMC8087994</accession><cross_references><pubmed>33981184</pubmed><doi>10.1155/2021/8876484</doi></cross_references></HashMap>